Examples of using Surface antigen in English and their translations into Danish
{-}
-
Medicine
-
Official
-
Colloquial
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
Infants born of hepatitis B virus surface antigen(HBsAg)-positive mothers should receive Hepatitis B Immune Globulin(HBIG)
Spædbørn født af overflade- antigen hepatitis B virus(HbsAg)- positive mødre bør få hepatitis B immunglobulin(HBIG) og hepatitis B vaccine(rekombinant)hepatitis B surface antigen or Hib conjugate e. g.
hepatitis B overflade antigen eller konjugeret Hib f. eks.other proteins purified from B. pertussis;• surface antigen(proteins from the surface)
tetanus• toxoider og andre proteiner oprenset fra B. pertussis• overfladeantigen(proteiner fra overfladen)While it is not expected that recombinant hepatitis B virus surface antigen would have adverse effects on pregnancies
Det forventes ikke, at rekombinant hepatitis B- virus overflade- antigen medfører bivirkinger ved graviditet eller på forsteret10 micrograms of recombinant hepatitis B surface antigen is recommended.
hepatitis A virus og 10 mikrogram rekombinant hepatitis B overflade antigen.Adsorbed hepatitis B surface antigen produced in recombinant yeast cells(Saccharomyces cerevisiae)- 5.0 µg.
Hepatitis B overflade- antigen, adsorberet, fremstillet i rekombinante gærceller Saccharomyces cerevisiae.purified hepatitis B surface antigen(HBsAg), separately adsorbed onto aluminium hydroxide and aluminium phosphate.
oprensede hepatitis B overflade antigen(HBsAg), separat adsorberede til hydreret aluminiumoxid og aluminiumphosphat.In vaccinees with an impaired immune system, administration of additional doses of vaccine should be considered if the antibody level against hepatitis B virus surface antigen(anti-HBsAg) is less than 10 IU/ l.
Hos personer med nedsat immunforsvar skal det overvejes at administrere yderligere vaccinedoser, hvis antistofniveauet mod hepatitis B virus overflade- antigen(anti- HBsAg) er mindre end 10 IE/ l.purified hepatitis B surface antigen(HBsAg), separately adsorbed onto aluminium hydroxide and aluminium phosphate.
oprensede hepatitis B overflade antigen(HBsAg), separat adsorberede til hydreret aluminiumoxid og aluminiumphosphat.attached to a carrier(a protein purified from the outer membrane of the bacterium Neisseria meningitidis);• surface antigen(proteins from the surface)
der er oprenset fra Hib og koblet til en bærer(et protein oprenset fra ydermembranen af bakterien Neisseria meningitidis),• overfladeantigener, dvs. proteiner fra overfladen,10 micrograms of recombinant hepatitis B surface antigen.
hepatitis A virus og 10 microgram rekombinant hepatitis B overfladeantigen.The protective efficacy of a dose of hepatitis B immunoglobulin at birth followed by 3 doses of a previous formulation of Merck' s recombinant hepatitis B vaccine has been demonstrated for neonates born to mothers positive for both hepatitis B virus surface antigen(HBsAg) and hepatitis B virus e antigen HBeAg.
Den beskyttende effekt af en dosis hepatitis B immunglobulin ved fødslen efterfulgt af 3 doser af en tidligere formulering af Mercks rekombinant hepatitis B vaccine er vist hos spædbørn, som er født af både hepatitis B virus overflade- antigen(HBsAg) og hepatitis B virus e- antigen(HBeAg) positive mødre.10 micrograms of recombinant hepatitis B surface antigen, were not statistically different.
af formalin inaktiveret hepatitis A virus og 10 mikrogram rekombinant hepatitis B overfladeantigen.10µg of recombinant hepatitis B surface antigen in a dose volume of 0.5 ml.
hepatitis A- virus og 10µg rekombinant hepatitis B overfladeantigen i en dosis på 0, 5 ml.the human immunodeficiency virus type I and II and the surface antigen of hepatitis B virus.
human immundefekt virus type I og II og overfladeantigenet til hepatitis B-virus.were seropositive at screening for hepatitis B(surface antigen positive) and/
seropositive ved screening for hepatitis B(surface antigen positive) og/10 micrograms of recombinant hepatitis B surface antigen.
hepatitis A virus og 10 mikrogram rekombinant hepatitis B overflade antigen.10 micrograms of recombinant hepatitis B surface antigen in a dose volume of 0.5 ml(recommended for subjects 1 year up to and including 15 years of age) or 720 ELISA Units of formalin inactivated hepatitis A virus and 20 micrograms of recombinant hepatitis B surface antigen in a dose volume of 1 ml(recommended from the age of 16 years onwards), the following adverse reactions have been reported.
af formalin inaktiveret hepatitis A virus og 10 mikrogram rekombinant hepatitis B overfladeantigen i en dosis på 0, 5 ml( anbefales til personer fra 1 år til og med 15 år) eller 720 ELISA enheder af formalin inaktiveret hepatitis A virus og 20 mikrogram rekombinant hepatitis B overfladeantigen i en dosis på 1 ml( anbefales til personer fra og med 16 år), er følgende bivirkninger blevet rapporteret.Influenza virus surface antigens(haemagglutinin and neuraminidase)* of strain.
Influenzavirus overfladeantigen(hæmagglutinin og neuraminidase)* af følgende stamme.Influenza virus surface antigens(haemagglutinin and neuraminidase)*,
Influenzavirus- overfladeantigener(hæmagglutinin og neuraminidase)*, inaktiveret,
